Loading
Loading
We use strictly necessary cookies to run this site, and analytics cookies to understand how it's used. See our Privacy Policy for details.
OpenAI Group PBC revealed today that it has acquired drug development software startup Orchestra Bio Inc.
Summary
Orchestra builds artificial intelligence agents that help pharmaceutical teams keep development programs on track,. Its staff and technology will now sit inside OpenAI’s Rosalind life sciences unit.
This is a brief wire summary, the full story (linked below) has the complete details.
KazaSec's take
AI-related security incidents are a genuinely new category, prompt injection, model manipulation, and data leakage through an LLM integration don't map cleanly onto traditional application security testing, and are worth assessing deliberately rather than assuming existing controls already cover them.
Coverage details
We've archived 896 other articles touching the same topic (the-latest, life sciences, anthropic) , see the full security news archive.
Relevant from KazaSec
More coverage on this topic
We help organizations find and fix the gaps before they make headlines.